A detailed history of Pluribus Labs, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Pluribus Labs, LLC holds 1,509 shares of MCK stock, worth $874,827. This represents 0.9% of its overall portfolio holdings.

Number of Shares
1,509
Previous 831 81.59%
Holding current value
$874,827
Previous $254,000 93.7%
% of portfolio
0.9%
Previous 1.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$300.57 - $336.42 $203,786 - $228,092
678 Added 81.59%
1,509 $492,000
Q1 2022

May 16, 2022

BUY
$244.61 - $310.48 $244 - $310
1 Added 0.12%
831 $254,000
Q4 2021

Feb 14, 2022

BUY
$198.21 - $248.9 $164,514 - $206,587
830 New
830 $206,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Pluribus Labs, LLC Portfolio

Follow Pluribus Labs, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pluribus Labs, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pluribus Labs, LLC with notifications on news.